| Compound Information | SONAR Target prediction |
| Name: | Ceftazidime pentahydrate |
| Unique Identifier: | Prest1094 |
| MolClass: | Checkout models in ver1.5 and ver1.0 |
| Molecular Formula: | C22H32N6O12S2 |
| Molecular Weight: | 605.409 g/mol |
| X log p: | 10.131 (online calculus) |
| Lipinksi Failures | 1 |
| TPSA | 182.14 |
| Hydrogen Bond Donor Count: | 0 |
| Hydrogen Bond Acceptors Count: | 10 |
| Rotatable Bond Count: | 10 |
| Canonical Smiles: | O.O.O.O.O.[O-]C(=O)C1N2C(SCC=1C[n+]1ccccc1)C(NC(=O)C(=NOC(C)(C)C(O)=O) c1csc(N)n1)C2=O |
| Generic_name: | Ceftazidime |
| Chemical_iupac_name: | 8-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-7-oxo -4-(pyridin-1-ylmethyl)-2-thia-6-azabicyclo[4.2.0]oct-4-ene-5-carboxylate |
| Drug_type: | Approved Drug |
| Pharmgkb_id: | PA448861 |
| Kegg_compound_id: | C06889 |
| Drugbank_id: | APRD00857 |
| H2o_solubility: | 396 mg/L |
| Logp: | -1.6 |
| Cas_registry_number: | 78439-06-2 |
| Drug_category: | Anti-Bacterial Agents; ATC:J01DD02 |
| Indication: | For the treatment of patients with infections caused by susceptible strains of organisms in the following diseases: lower respiratory tract infections,skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra abdominal infections (including peritonitis), and central nervous system infections (including meningitis). |
| Pharmacology: | Ceftazidime is a semisynthetic, broad-spectrum, beta-lactam antibiotic for parenteral administration. Ceftazidime is bactericidal in action exerting its effect by inhibition of enzymes responsible for cell-wall synthesis. A wide range of gram-negative organisms is susceptible to ceftazidime in vitro, including strains resistant to gentamicin and other aminoglycosides. In addition, ceftazidime has been shown to be active against gram-positive organisms. It is highly stable to most clinically important beta-lactamases, plasmid or chromosomal, which are produced by both gram-negative and gram-positive organisms and, consequently, is active against many strains resistant to ampicillin and other cephalosporins. Ceftazidime has activity against the gram-negative organisms Pseudomonas and Enterobacteriaceae. Its activity against Pseudomonas is a distinguishing feature of ceftazidime among the cephalosporins. |
| Mechanism_of_action: | The bactericidal activity of ceftazidime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). |
| Organisms_affected: | Enteric bacteria and other eubacteria |
| Found: 3 nonactive as graph: single | with analogs | 1 2 3 Next >> |
| Species: | 9606 |
| Condition: | TMPPre001 |
| Replicates: | 2 |
| Raw OD Value: r im | 1971.0000±0 |
| Normalized OD Score: sc h | 0.9739±0 |
| Z-Score: | -0.5874±0 |
| p-Value: | 0.556926 |
| Z-Factor: | -8.93985 |
| Fitness Defect: | 0.5853 |
| Bioactivity Statement: | Nonactive |
| ps |
| DBLink | Rows returned: 17 | 1 2 3 Next >> |
| 2650 | 7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ylmeth yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| 2651 | 7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ylmeth yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| 54196 | (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin- 1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate pentahydrate |
| 54197 | (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin- 1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| 91713 | (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin- 1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| 5362051 | (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyr idin-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate pentahydrate |
| internal high similarity DBLink | Rows returned: 0 |
| active | Cluster 437 | Additional Members: 14 | Rows returned: 2 |
| SPE01503111 | 0.340425531914894 |
| SPE01502033 | 0.289156626506024 |
Service provided by the
Mike Tyers Laboratory